Clinical Research Studies

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Depressive Symptoms
• Age: Between 18 - 100 Years
• Gender: Male or Female

• Other Inclusion Criteria:
  

  1. Currently meets ICHD-3 criteria for migraine using the Structured Diagnostic Interview for Headache
  2. Self-reported 4-14 headache days per month, with at least one attack meeting migraine criteria
  3. Score between 5-14 on the PHQ-9
  4. Ability to read and speak English
  5. Able to provide written informed consent form

  
  

You may not be eligible for this study if the following are true:

• 1. Meeting ICHD-3 criteria for persistent headache attributed to traumatic injury to the head (post-traumatic headache) on the Structure Diagnostic Interview for Headache
  2. Changes in preventive migraine medication or anti-depressant medication within 6 weeks of intake; changes in longer-term migraine prevention (onobotulinum toxin A, anti-calcitonin gene related peptide treatment) within 3 months of intake
  3. Comorbid psychiatric illness or clinical features that would interfere with participant’s ability to participate in or receive benefit from the MBCT-T intervention, including but not limited to: active suicidal ideation; recent history of psychosis or mania; borderline, histrionic or narcissistic personality disorder; cognitive impairment; sensory disabilities; bipolar disorder; obsessive-compulsive disorder
  4. Prior history of engaging in formal mindfulness-based interventions including: MBSR, MBCT, Acceptance and Commitment therapy, Dialectical Behavior Therapy
  5. Current meditation practice >3x/week